In vivo purging with Rituximab before autologous peripheral blood progenitor cell (PBPC) transplantation in lymphoma patients (PTS).

被引：0
|
作者：
Salles, G [1 ]
Moullet, I [1 ]
Charlot, C [1 ]
Thieblemont, C [1 ]
Bouafia, F [1 ]
Dumontet, C [1 ]
Espinouse, D [1 ]
Coiffier, B [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Hematol Serv, F-69310 Pierre Benite, France
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
619
引用
收藏
页码：141A / 141A
页数：1
相关论文
共 50 条
  • [31] Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children with leukemia.
    Madero, L
    Diaz, MA
    Benito, A
    Alegre, A
    Villa, M
    BLOOD, 1996, 88 (10) : 3829 - 3829
  • [32] Evaluation of single-dose palifermin to reduce mucositis: Assessment of efficacy and safety in patients (PTS) with hematologic malignancies (HM) receiving autologous peripheral blood progenitor cell (PBPC) transplantation
    Shea, T.
    Kewalramani, T.
    Mun, Y.
    Jayne, J.
    Dreiling, L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 79 - 80
  • [33] Performance status at presentation predicts for survival after autologous peripheral blood progenitor cell (PBPC) transplantation in multiple myeloma
    Nagesh, K
    Robertson, J
    Howe, T
    Dougal, M
    Chang, J
    Morgenstern, GR
    Chopra, R
    Scarffe, JH
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 93 - 93
  • [34] Mobilization and transplantation of autologous peripheral blood progenitor cells (PBPC) in patients with chronic myeloid leukemia (CML) at high risk
    Link, H
    Arseniev, L
    Nolte, M
    Werner, M
    Battmer, K
    Stucki, A
    Diedrich, H
    Kadar, JG
    Bussing, B
    Hertenstein, B
    Ganser, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 326 - 326
  • [35] AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION
    ANDERSON, KC
    JOURNAL OF CLINICAL APHERESIS, 1995, 10 (03) : 131 - 138
  • [36] Autologous peripheral blood progenitor cell transplantation for multiple myeloma
    Attal, M
    Harousseau, JL
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (1-2) : 171 - 191
  • [37] Efficiency of in vivo purging with autologous stem cell transplantation and rituximab in B-CLL non-Hodgkin's lymphoma
    Tothova, E
    Stecova, N
    Kafkova, A
    Guman, T
    Fricova, M
    Svorcova, E
    BONE MARROW TRANSPLANTATION, 2003, 31 : S76 - S76
  • [38] Clinical implications or molecular monitoring in patients (PTS) with low-grade non-Hodgkin lymphoma (NHL) after transplantation of autologous bone marrow (BM) or peripheral blood progenitor cells (PBPC)
    vonNeuhoff, N
    Suttorp, M
    Dreger, P
    Loffler, H
    Schmitz, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1155 - 1155
  • [39] Rituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
    Zhang, Wei
    Jiao, Li
    Zhou, Dao-Bin
    Shen, Ti
    ONCOLOGY LETTERS, 2010, 1 (04) : 733 - 738
  • [40] Rituximab as in vivo purging agent in autologous stem cell transplantation for relapsed B-NHL
    Hess, G
    Flohr, T
    Derigs, HG
    ANNALS OF HEMATOLOGY, 2002, 81 : S54 - S55
12345